Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-19-001684

Options or other derivatives

  • Chief Scientific Officer acquired 56,875 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-02-06 Grant or award : show line 1 in the form Stock Option (right to buy) +48,750 48,750 D
2019-02-06 Grant or award : show line 2 in the form Restricted Stock Units +8,125 8,125 D
Loading xslF345X03/edgar.xml…